. 2015 Spring;8(Suppl 1):S1-5.

Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes

Affiliations

¹ Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
² Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁴ Department of Internal Medicine, Division of Gastroenterology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁶ Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 26171132
PMCID: PMC4495421

Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes

Masoud Alebouyeh et al. Gastroenterol Hepatol Bed Bench. 2015 Spring.

. 2015 Spring;8(Suppl 1):S1-5.

Affiliations

¹ Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
² Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁴ Department of Internal Medicine, Division of Gastroenterology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁶ Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 26171132
PMCID: PMC4495421

No abstract available

PubMed Disclaimer

Cited by

In silico approach towards the identification of potential inhibitors from Curcuma amada Roxb against H. pylori: ADMET screening and molecular docking studies.
Divyashri G, Krishna Murthy TP, Sundareshan S, Kamath P, Murahari M, Saraswathy GR, Sadanandan B. Divyashri G, et al. Bioimpacts. 2021;11(2):119-127. doi: 10.34172/bi.2021.19. Epub 2020 Mar 24. Bioimpacts. 2021. PMID: 33842282 Free PMC article.
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori.
Feng ZH, Fan L, Yang J, Huo XY, Guo Y, Zhang Y, Lan CH. Feng ZH, et al. BMC Microbiol. 2019 Aug 5;19(1):176. doi: 10.1186/s12866-019-1558-8. BMC Microbiol. 2019. PMID: 31382897 Free PMC article.
Management of multi-drug resistant Helicobacter pylori infection by supplementary, complementary and alternative medicine; a review.
Rezaeimanesh N, Farzi N, Pirmanesh S, Emami S, Yadegar A. Rezaeimanesh N, et al. Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S8-S14. Gastroenterol Hepatol Bed Bench. 2017. PMID: 29511465 Free PMC article. Review.
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.
Tshibangu-Kabamba E, Yamaoka Y. Tshibangu-Kabamba E, et al. Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):613-629. doi: 10.1038/s41575-021-00449-x. Epub 2021 May 17. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34002081 Review.
Characterization of clarithromycin heteroresistance among Helicobacter pylori strains isolated from the antrum and corpus of the stomach.
Farzi N, Behzad C, Hasani Z, Alebouyeh M, Zojaji H, Zali MR. Farzi N, et al. Folia Microbiol (Praha). 2019 Mar;64(2):143-151. doi: 10.1007/s12223-018-0637-9. Epub 2018 Aug 10. Folia Microbiol (Praha). 2019. PMID: 30097895

See all "Cited by" articles

References

1. Vaziri F, Peerayeh SN, Alebouyeh M, Molaei M, Maghsoudi N, Zali MR. Determination of Helicobacter pyloricagA EPIYA types in Iranian isolates with different gastroduodenal disorders. Infect Genet Evol. 2013;17:101–5. - PubMed
1. Yadegar A, Mobarez AM, Alebouyeh M, Mirzaei T, Kwok T, Zali MR. Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran. World J Microbiol Biotechnol. 2014;30:2481–90. - PubMed
1. Molina‐Infante J, Perez‐Gallardo B, Fernandez‐Bermejo M, Hernandez‐Alonso M, Vinagre G, Duenas C, et al. Clinical trial: clarithromycin vs levofloxacin in first‐line triple and sequential regimens for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2010;31:1077–84. - PubMed
1. Zali MR. Facing resistance of H pylori infection. Gastroenterol Hepatol Bed Bench. 2011;4 - PMC - PubMed
1. Hunt R, Xiao S, Megraud F, LeonBarua R, Bazzoli F, Van Der Merwe S, et al. World Gastroenterology Organisation Global Guideline: Helicobacter pylori in developing countries. J Clin Gastroenterol. 2011;45:383–8. - PubMed

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes

Affiliations

Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes

Authors

Affiliations

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources